{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:35:30Z","timestamp":1788388530472,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There has been a notable shift towards the diagnosis of less severe and asymptomatic primary hyperparathyroidism (PHPT) in developed countries. However, there is a paucity of recent data from sub-Saharan Africa (SSA), and also, no reported data from SSA on the utility of intra-operative parathyroid hormone (IO-PTH) monitoring. In an earlier study from Inkosi Albert Luthuli Central Hospital (IALCH), Durban, South Africa (2003\u20132009), majority of patients (92.9%) had symptomatic disease. The aim of this study was to evaluate the clinical profile and management outcomes of patients presenting with PHPT at IALCH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective chart review of patients with PHPT attending the Endocrinology clinic at IALCH between July 2009 and December 2021. Clinical presentation, laboratory results, radiologic findings, surgical notes and histology were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Analysis included 110 patients (87% female) with PHPT. Median age at presentation was 57 (44; 67.5) years. Symptomatic disease was present in 62.7% (n:69); 20.9% (n:23) had a history of nephrolithiasis and 7.3% (n:8) presented with previous fragility fractures. Mean serum calcium was 2.87\u2009\u00b1\u20090.34 mmol\/l; median serum-PTH was 23.3 (15.59;\u00a045.38) pmol\/l, alkaline phosphatase 117.5 (89;\u00a0145.5) U\/l and 25-hydroxyvitamin-D 42.9 (33.26;\u00a062.92) nmol\/l. Sestamibi scan (n:106 patients) identified an adenoma in 83.02%. Parathyroidectomy was performed on 84 patients with a cure rate of 95.2%. Reasons for conservative management (n:26) included: no current surgical indication (n:7), refusal (n:5) or deferral of surgery (n:5), loss to follow-up (n:5) and assessed as high anaesthetic risk (n:4). IO-PTH measurements performed on 28 patients indicated surgical success in 100%, based on Miami criteria. Histology confirmed adenoma in 88.1%, hyperplasia in 7.1% and carcinoma in 4.8%. Post-operative hypocalcaemia developed in 30 patients (35.7%), of whom, 14 developed hungry bone syndrome (HBS). In multivariate analysis, significant risk factors associated with HBS included male sex (OR 7.01; 95% CI 1.28, 38.39; p 0.025) and elevated pre-operative PTH (OR 1.01; 95% CI 1.00, 1.02; p 0.008).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The proportion of asymptomatic PHPT has increased at this centre over the past decade but symptomatic disease remains the dominant presentation. Parathyroidectomy is curative in the majority of patients. IO-PTH monitoring is valuable in ensuring successful surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-024-01583-8","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:01:44Z","timestamp":1714003304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa"],"prefix":"10.1186","volume":"24","author":[{"given":"Kamal","family":"Govind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran M.","family":"Paruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha A.","family":"Motala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"issue":"10116","key":"1583_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism Lancet. 2018;391(10116):168\u201378.","journal-title":"Hyperparathyroidism Lancet"},{"key":"1583_CR2","doi-asserted-by":"crossref","unstructured":"Zhu CY, Sturgeon C, Yeh MW. Diagnosis and management of primary hyperparathyroidism. JAMA. 2020.","DOI":"10.1001\/jama.2020.0538"},{"issue":"2","key":"1583_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Reviews Endocrinol. 2018;14(2):115\u201325.","journal-title":"Nat Reviews Endocrinol"},{"issue":"11","key":"1583_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","volume":"379","author":"KL Insogna","year":"2018","unstructured":"Insogna KL. Primary hyperparathyroidism. N Engl J Med. 2018;379(11):1050\u20139.","journal-title":"N Engl J Med"},{"issue":"9","key":"1583_CR5","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1007\/s00268-018-4575-0","volume":"42","author":"SK Yadav","year":"2018","unstructured":"Yadav SK, Mishra SK, Mishra A, Mayilvagnan S, Chand G, Agarwal G, et al. Changing Profile of primary hyperparathyroidism over two and half decades: a study in Tertiary Referral Center of North India. World J Surg. 2018;42(9):2732\u20137.","journal-title":"World J Surg"},{"key":"1583_CR6","doi-asserted-by":"crossref","unstructured":"Sun B, Guo B, Wu B, Kang J, Deng X, Zhang Z et al. Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016. Osteoporosis International: A Journal established as result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2018;29(3):635\u201342.","DOI":"10.1007\/s00198-017-4322-7"},{"key":"1583_CR7","doi-asserted-by":"crossref","unstructured":"Rojas AP, Fain K, Peiris AN. Resolution of hypercalcemia in primary hyperparathyroidism with vitamin D replacement. Proceedings (Baylor University Medical Center). 2019;33(1):40\u2009\u2013\u20091.","DOI":"10.1080\/08998280.2019.1680060"},{"issue":"1","key":"1583_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12020-016-1169-1","volume":"55","author":"MD Walker","year":"2017","unstructured":"Walker MD, Bilezikian JP. Vitamin D and primary hyperparathyroidism: more insights into a complex relationship. Endocrine. 2017;55(1):3\u20135.","journal-title":"Endocrine"},{"issue":"4","key":"1583_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3803\/EnM.2019.34.4.327","volume":"34","author":"ZF Khan","year":"2019","unstructured":"Khan ZF, Lew JI. Intraoperative parathyroid hormone monitoring in the Surgical Management of sporadic primary hyperparathyroidism. Endocrinol Metabolism (Seoul Korea). 2019;34(4):327\u201339.","journal-title":"Endocrinol Metabolism (Seoul Korea)"},{"issue":"1057","key":"1583_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/postgradmedj-2012-131707","volume":"89","author":"IM Paruk","year":"2013","unstructured":"Paruk IM, Esterhuizen TM, Maharaj S, Pirie FJ, Motala AA. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience. Postgrad Med J. 2013;89(1057):626\u201331.","journal-title":"Postgrad Med J"},{"issue":"1","key":"1583_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/16089677.2020.1843841","volume":"26","author":"M Budge","year":"2021","unstructured":"Budge M, Conradie W, Beviss-Challinor K, Martin L, Conradie M, Coetzee A. Bone health in patients undergoing surgery for primary hyperparathyroidism at Tygerberg Hospital, Cape Town, South Africa. J Endocrinol Metabolism Diabetes South Afr. 2021;26(1):16\u201323.","journal-title":"J Endocrinol Metabolism Diabetes South Afr"},{"issue":"9","key":"1583_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, et al. A New equation to Estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1583_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.amsu.2015.08.007","volume":"4","author":"AA Khan","year":"2015","unstructured":"Khan AA, Khatun Y, Walker A, Jimeno J, Hubbard JG. Role of intraoperative PTH monitoring and surgical approach in primary hyperparathyroidism. Annals Med Surg. 2015;4(3):301\u20135.","journal-title":"Annals Med Surg"},{"issue":"3","key":"1583_CR14","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/EJE-12-0528","volume":"168","author":"JE Witteveen","year":"2013","unstructured":"Witteveen JE, vTS, Romijn JA, Hamdy NA. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013;168(3):R45\u201353.","journal-title":"Eur J Endocrinol"},{"key":"1583_CR15","doi-asserted-by":"crossref","unstructured":"Yadav SK, Johri G, Bichoo RA, Jha CK, Kintu-Luwaga R, Mishra SK. Primary hyperparathyroidism in developing world: a systematic review on the changing clinical profile of the disease. Archives Endocrinol Metabolism. 2020;64.","DOI":"10.20945\/2359-3997000000211"},{"key":"1583_CR16","doi-asserted-by":"crossref","unstructured":"Lin X, Fan Y, Zhang Z, Yue H. Clinical characteristics of primary hyperparathyroidism: 15-Year experience of 457 patients in a single Center in China. Front Endocrinol. 2021;12.","DOI":"10.3389\/fendo.2021.602221"},{"key":"1583_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3342\/kjorl-hns.2022.00332","volume":"65","author":"DK Ahn","year":"2022","unstructured":"Ahn DK. Ji. Role and recent Trend of intraoperative parathyroid hormone monitoring during parathyroidectomy in patients with primary hyperparathyroidism. Korean J Otorhinolaryngology-Head Neck Surg. 2022;65:253\u20139.","journal-title":"Korean J Otorhinolaryngology-Head Neck Surg"},{"issue":"6","key":"1583_CR18","doi-asserted-by":"publisher","first-page":"zrac118","DOI":"10.1093\/bjsopen\/zrac118","volume":"6","author":"L Hargitai","year":"2022","unstructured":"Hargitai L, Bereuter CM, Dunkler D, Geroldinger A, Scheuba C, Niederle B, et al. The value of intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and varying baseline parathyroid hormone levels. BJS Open. 2022;6(6):zrac118.","journal-title":"BJS Open"},{"issue":"1","key":"1583_CR19","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1038\/s41598-022-07380-4","volume":"12","author":"G Graceffa","year":"2022","unstructured":"Graceffa G, Cipolla C, Calagna S, Contino S, Melfa G, Orlando G, et al. Interpretation of intraoperative parathyroid hormone monitoring according to the Rome criterion in primary hyperparathyroidism. Sci Rep. 2022;12(1):3333.","journal-title":"Sci Rep"},{"key":"1583_CR20","doi-asserted-by":"publisher","first-page":"6282687","DOI":"10.1155\/2018\/6282687","volume":"2018","author":"L Meng","year":"2018","unstructured":"Meng L, Liu S, Al-Dayyeni A, Sheng Z, Zhou Z, Wang X. Comparison of initial clinical presentations between primary hyperparathyroidism patients from New Brunswick and Changsha. Int J Endocrinol. 2018;2018:6282687.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"1583_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4248\/BR201302005","volume":"1","author":"J-m Liu","year":"2013","unstructured":"Liu J-m, Cusano NE, Silva BC, Zhao L, He X-y, Tao B, et al. Primary hyperparathyroidism: a tale of two cities revisited \u2014 New York and Shanghai. Bone Res. 2013;1(1):162\u20139.","journal-title":"Bone Res"},{"issue":"1","key":"1583_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12902-022-01059-7","volume":"22","author":"Y Al-Saleh","year":"2022","unstructured":"Al-Saleh Y, AlSohaim A, AlAmoudi R, AlQarni A, Alenezi R, Mahdi L, et al. Primary hyperparathyroidism in Saudi Arabia revisited: a multi-centre observational study. BMC Endocr Disorders. 2022;22(1):155.","journal-title":"BMC Endocr Disorders"},{"issue":"6","key":"1583_CR23","first-page":"413","volume":"22","author":"MCN Pawlowska","year":"2015","unstructured":"Pawlowska MCN. An overview of normocalcemic primary hyperparathyroidism. Current opinion in Endocrinology. Diabetes Obes. 2015;22(6):413\u201321.","journal-title":"Diabetes Obes"},{"key":"1583_CR24","doi-asserted-by":"crossref","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE-H, Marcocci C, Minisola S et al. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop. Journal of Bone and Mineral Research. 2022;37(11):2293\u2009\u2013\u2009314.","DOI":"10.1002\/jbmr.4677"},{"key":"1583_CR25","doi-asserted-by":"crossref","unstructured":"Schini M, Jacques R, Oakes E, Peel N, Walsh J, Eastell R. Normocalcemic hyperparathyroidism: study of its prevalence and natural history. The Journal of Clinical Endocrinology & Metabolism; 2020.","DOI":"10.1210\/clinem\/dgaa084"},{"issue":"9","key":"1583_CR26","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1210\/jc.2015-2022","volume":"100","author":"MDCE Walker","year":"2015","unstructured":"Walker MDCE, Lee JA, et al. Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J Clin Endocrinol Metab. 2015;100(9):3443\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1583_CR27","first-page":"56","volume":"70","author":"GAB \u015eeng\u00fcl Ay\u00e7i\u00e7ek","year":"2023","unstructured":"\u015eeng\u00fcl Ay\u00e7i\u00e7ek GAB, \u015eahin M, Emral R, Erdo\u011fan MF, G\u00fcll\u00fc S, Ba\u015fkal N, \u00c7orap\u00e7\u0131o\u011flu D. The impact of vitamin D deficiency on clinical, biochemical and metabolic parameters in primary hyperparathyroidism. Endocrinol Diabetes Nutr (Engl Ed). 2023;70(1):56\u201362.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"9","key":"1583_CR28","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1210\/jc.2015-2022","volume":"100","author":"MD Walker","year":"2015","unstructured":"Walker MD, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ, et al. Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J Clin Endocrinol Metabolism. 2015;100(9):3443\u201351.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"1583_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/SLA.0b013e318208fed9","volume":"253","author":"RLZ Udelsman","year":"2011","unstructured":"Udelsman RLZ, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011;253(3):585\u201391.","journal-title":"Ann Surg"},{"key":"1583_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.sopen.2021.02.002","volume":"4","author":"S Nouikes Zitouni","year":"2021","unstructured":"Nouikes Zitouni S. Monocentric experience of primary hyperparathyroidism surgery in Algeria. Surg Open Sci. 2021;4:32\u20136.","journal-title":"Surg Open Sci"},{"key":"1583_CR31","doi-asserted-by":"crossref","unstructured":"Mallikarjuna VM, Vivek and Ayyar, Vageesh and Bantwal, Ganapathy and Ganesh, Vaishnavi and George, Belinda and Hemanth, GN and, Vinotha P. Five-year Retrospective Study on Primary Hyperparathyroidism in South India: Emerging Roles of Minimally Invasive Parathyroidectomy and Preoperative Localization with Methionine Positron Emission Tomography-Computed Tomography Scan. Indian Journal of Endocrinology and Metabolism. 2018;22:355.","DOI":"10.4103\/ijem.IJEM_445_16"},{"key":"1583_CR32","doi-asserted-by":"crossref","unstructured":"Tay D, Das JP, Yeh R. Preoperative localization for primary hyperparathyroidism: a clinical review. Biomedicines. 2021;9(4).","DOI":"10.3390\/biomedicines9040390"},{"issue":"6","key":"1583_CR33","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.2214\/AJR.06.0938","volume":"188","author":"NA Johnson","year":"2007","unstructured":"Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. Am J Roentgenol. 2007;188(6):1706\u201315.","journal-title":"Am J Roentgenol"},{"issue":"6","key":"1583_CR34","first-page":"e4960","volume":"11","author":"W Abd Elhameed Elsayed","year":"2019","unstructured":"Abd Elhameed Elsayed W, Ali RA. Efficacy of Scintigraphy, Ultrasound and both Scintigraphy and Ultrasonography in Preoperative Detection and localization of primary hyperparathyroidism. Cureus. 2019;11(6):e4960.","journal-title":"Cureus"},{"key":"1583_CR35","doi-asserted-by":"crossref","unstructured":"Jakubauskas MB, Strupas V. K\u0119stutis. Risk factors of developing the hungry bone syndrome after parathyroidectomy for primary hyperparathyroidism. Acta Med Lituanica. 2018;25.","DOI":"10.6001\/actamedica.v25i1.3703"},{"key":"1583_CR36","doi-asserted-by":"crossref","unstructured":"Kaya C, Tam AA, Diriko\u00e7 A, K\u0131l\u0131\u00e7yazgan A, K\u0131l\u0131\u00e7 M, T\u00fcrk\u00f6lmez \u015e et al. Hypocalcemia development in patients operated for primary hyperparathyroidism: can it be predicted preoperatively? Archives Endocrinol Metabolism. 2016;60.","DOI":"10.1590\/2359-3997000000207"},{"issue":"5","key":"1583_CR37","first-page":"310","volume":"67","author":"AJ Guill\u00e9n Mart\u00ednez","year":"2020","unstructured":"Guill\u00e9n Mart\u00ednez AJ, Smilg Nicol\u00e1s C, Moraleda Deleito J, Guill\u00e9n Mart\u00ednez S, Garc\u00eda-Purri\u00f1os Garc\u00eda F. Risk factors and evolution of calcium and parathyroid hormone levels in hungry bone syndrome after parthyroidectomy for primary hyperparathyroidism. Endocrinolog\u00eda Diabetes Y Nutrici\u00f3n (English ed). 2020;67(5):310\u20136.","journal-title":"Endocrinolog\u00eda Diabetes Y Nutrici\u00f3n (English ed)"},{"issue":"1","key":"1583_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.afos.2022.03.004","volume":"8","author":"M Chandran","year":"2022","unstructured":"Chandran M, Bilezikian JP, Salleh NM, Ying H, Lau J, Lee J, et al. Hungry bone syndrome following parathyroidectomy for primary hyperparathyroidism in a developed country in the Asia Pacific. A cohort study. Osteoporos Sarcopenia. 2022;8(1):11\u20136.","journal-title":"Osteoporos Sarcopenia"},{"issue":"3","key":"1583_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00774-005-0680-x","volume":"24","author":"IT Lee","year":"2006","unstructured":"Lee IT, Sheu WH-H, Tu S-T, Kuo S-W, Pei D. Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism. J Bone Miner Metab. 2006;24(3):255\u20138.","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"1583_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/2230-8210.196023","volume":"21","author":"SVSH Mayilvaganan","year":"2017","unstructured":"Mayilvaganan SVSH, Shivaprasad C. Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism. Indian J Endocrinol Metab. 2017;21(1):76\u20139.","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"1583_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1590\/S0482-50042011000200003","volume":"51","author":"TCGL Fran\u00e7a","year":"2011","unstructured":"Fran\u00e7a TCGL, Pinho J, Diniz ET, Andrade LD, Lucena CS, Beserra SR, Asano NM, Duarte AP, Bandeira F. Bisphosphonates can reduce bone hunger after parathyroidectomy in patients with primary hyperparathyroidism and osteitis fibrosa cystica. Rev Bras Reumatol. 2011;51(2):131\u20137.","journal-title":"Rev Bras Reumatol"},{"issue":"2","key":"1583_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1055\/a-1325-0351","volume":"71","author":"RGA Pal","year":"2021","unstructured":"Pal RGA, Bhadada SK. Role of bisphosphonates in the Prevention of Postoperative Hungry Bone Syndrome in primary hyperparathyroidism: a Meta-analysis and need for randomized controlled trials. Drug Res (Stuttg). 2021;71(2):108\u20139.","journal-title":"Drug Res (Stuttg)"},{"issue":"1","key":"1583_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12902-020-00622-4","volume":"20","author":"S Lu","year":"2020","unstructured":"Lu S, Gong M, Zha Y, Cui A, Chen C, Sun W, et al. Identification of independent factors affecting bone mineral density after successful parathyroidectomy for symptomatic hyperparathyroidism. BMC Endocr Disorders. 2020;20(1):141.","journal-title":"BMC Endocr Disorders"},{"key":"1583_CR44","doi-asserted-by":"crossref","unstructured":"Lu SG, Maoqi; Zha Y, Cui A, Chen C, Yang H, Sun W, Hua K, Tian W. Jiang, Xieyuan. Changes in bone mineral density after parathyroidectomy in patients with moderate to severe primary hyperparathyroidism. J Int Med Res. 2020;48.","DOI":"10.1177\/0300060520964698"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01583-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01583-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:04:13Z","timestamp":1714003453000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01583-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01583-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3873001\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"17 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the University of KwaZulu-Natal Biomedical Research Ethics committee (BREC) [reference number: BREC\/00001483\/2020]. Individual participant consent was waived as this was a retrospective chart review and patients were not put at risk. Consent was waived to Inkosi Albert Luthuli Central Hospital (IALCH) and KwaZulu-Natal Department of Health, both of which granted permission to access patient information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}